CRISPR Therapeutics
CRSP
#3582
Rank
A$5.80 B
Marketcap
A$59.88
Share price
0.10%
Change (1 day)
-27.29%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2026 (TTM): A-$6.91

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is A-$7.06. In 2025 the company made an earnings per share (EPS) of A-$9.71 a decrease over its 2024 EPS that were of A-$6.51.

EPS history for CRISPR Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$6.91-28.86%
2025A-$9.7149.2%
2024A-$6.51
2022A-$12.47-267.74%
2021A$7.43
2019A$1.65-132.36%
2018A-$5.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.01-71.52%๐Ÿ‡บ๐Ÿ‡ธ USA